Cargando…

Harnessing Radiation Biology to Augment Immunotherapy for Glioblastoma

Glioblastoma is the most common adult primary brain tumor and carries a dismal prognosis. Radiation is a standard first-line therapy, typically deployed following maximal safe surgical debulking, when possible, in combination with cytotoxic chemotherapy. For other systemic cancers, standard of care...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rajani, Karishma R., Carlstrom, Lucas P., Parney, Ian F., Johnson, Aaron J., Warrington, Arthur E., Burns, Terry C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2019
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6395389/ https://www.ncbi.nlm.nih.gov/pubmed/30854331 http://dx.doi.org/10.3389/fonc.2018.00656

Ejemplares similares

Harnessing the Power of Onco-Immunotherapy with Checkpoint Inhibitors
por: Rajani, Karishma R., et al.
Publicado: (2015)

Selective Vulnerability of Senescent Glioblastoma Cells to BCL-XL Inhibition
por: Rahman, Masum, et al.
Publicado: (2022)

Radiation-Induced Alterations in the Recurrent Glioblastoma Microenvironment: Therapeutic Implications
por: Gupta, Kshama, et al.
Publicado: (2018)

DDRE-12. HETEROGENOUS RESPONSE OF IDH-MUTANT AND IDH-WT GLIOMA TO NAMPT INHIBITION
por: Rahman, Masum, et al.
Publicado: (2021)

Immunosuppression in Glioblastoma: Current Understanding and Therapeutic Implications
por: Himes, Benjamin T., et al.
Publicado: (2021)

Radiation Induced Metabolic Alterations Associate With Tumor Aggressiveness and Poor Outcome in Glioblastoma
por: Gupta, Kshama, et al.
Publicado: (2020)

Harnessing the Immunomodulatory Effects of Radiation in Urinary Bladder Cancer
por: Abbas, Waseem, et al.
Publicado: (2019)

BIMG-20. METABOLIC BIOMARKERS IN MICRODIALYSATE OF IDH-1 MUTANT TUMORS
por: Rajani, Karishma, et al.
Publicado: (2021)

Harnessing DNA Repair Defects to Augment Immune-Based Therapies in Triple-Negative Breast Cancer
por: Clark, Curtis A., et al.
Publicado: (2021)

Isolation and Analysis of Plasma-Derived Exosomes in Patients With Glioma
por: Cumba Garcia, Luz M., et al.
Publicado: (2019)

Harnessing the Immunological Effects of Radiation to Improve Immunotherapies in Cancer
por: Hannon, Gary, et al.
Publicado: (2023)

Immunotherapy and Epigenetic Pathway Modulation in Glioblastoma Multiforme
por: Chin, Christopher, et al.
Publicado: (2018)

Cytomegalovirus as a Novel Target for Immunotherapy of Glioblastoma Multiforme
por: Schuessler, Andrea, et al.
Publicado: (2014)

Interactions Between Anti-Angiogenic Therapy and Immunotherapy in Glioblastoma
por: Jain, Saket, et al.
Publicado: (2022)

Ionizing Radiation in Glioblastoma Initiating Cells
por: Rivera, Maricruz, et al.
Publicado: (2013)

BT-06 CENTRAL NERVOUS SYSTEM HEMANGIOBLASTOMA; DIFFERENCES IN CLINICAL PICTURE OF SPORADIC CASES AND VON-HIPPEL LINDAU DISEASE IN 184 CASES
por: Takami, Hirokazu, et al.
Publicado: (2019)

Adoptive Cell Therapy: A Novel and Potential Immunotherapy for Glioblastoma
por: Wang, Jingyu, et al.
Publicado: (2020)

Glioblastoma Organoids: Pre-Clinical Applications and Challenges in the Context of Immunotherapy
por: Klein, Eliane, et al.
Publicado: (2020)

Immunotherapy Plus Cryotherapy: Potential Augmented Abscopal Effect for Advanced Cancers
por: Abdo, Joe, et al.
Publicado: (2018)

Combinations of Immunotherapy and Radiation in Cancer Therapy
por: Vatner, Ralph E., et al.
Publicado: (2014)

Harnessing Lactate Metabolism for Radiosensitization
por: Liu, Kevin X., et al.
Publicado: (2021)

P21 Overexpression Promotes Cell Death and Induces Senescence in Human Glioblastoma
por: Mansour, Moustafa A., et al.
Publicado: (2023)

Harnessing the potential of radiation treatment of brain metastases to improve melanoma immunotherapy
por: McNeilly, Corey D, et al.
Publicado: (2015)

Exploiting Radiation Therapy to Restore Immune Reactivity of Glioblastoma
por: De Martino, Mara, et al.
Publicado: (2021)

Harnessing the immune system in glioblastoma
por: Brown, Nicholas F., et al.
Publicado: (2018)

Adjuvant Radiation in Older Patients With Glioblastoma: A Retrospective Single Institution Analysis
por: Lee, Jessica W., et al.
Publicado: (2021)

Clinical opportunities in combining immunotherapy with radiation therapy
por: Finkelstein, Steven E., et al.
Publicado: (2012)

Ultraviolet Radiation and Melanomagenesis: From Mechanism to Immunotherapy
por: Sun, Xiaoying, et al.
Publicado: (2020)

Immunotherapy Combined With Radiation Therapy for Genitourinary Malignancies
por: Ukleja, Jacob, et al.
Publicado: (2021)

Editorial: The Biological Landscape of Immunotherapy in AML
por: Isidori, Alessandro, et al.
Publicado: (2021)

Efficacy of Cytokine-Induced Killer Cell Immunotherapy for Patients With Pathologically Pure Glioblastoma
por: Han, Myung-Hoon, et al.
Publicado: (2022)

Biological Rationale for the Use of PPARγ Agonists in Glioblastoma
por: Ellis, Hayley Patricia, et al.
Publicado: (2014)

The Basis and Advances in Clinical Application of Cytomegalovirus-Specific Cytotoxic T Cell Immunotherapy for Glioblastoma Multiforme
por: Daei Sorkhabi, Amin, et al.
Publicado: (2022)

Epithelial-to-Mesenchymal Plasticity Harnesses Endocytic Circuitries
por: Corallino, Salvatore, et al.
Publicado: (2015)

PDPN marks a subset of aggressive and radiation-resistant glioblastoma cells
por: Modrek, Aram S., et al.
Publicado: (2022)

Harnessing Microglia and Macrophages for the Treatment of Glioblastoma
por: Prionisti, Ioanna, et al.
Publicado: (2019)

Editorial: Molecular biology of biomarkers in diagnosis and treatment of glioblastoma multiforme
por: Zhao, Jianyi, et al.
Publicado: (2023)

Harnessing Oncolytic Virus-Mediated Anti-Tumor Immunity
por: Schirrmacher, Volker, et al.
Publicado: (2014)

Editorial: Harnessing the Power of Patient Derived Models of Cancer
por: Pine, Sharon R., et al.
Publicado: (2018)

Editorial: Harnessing DNA Damage Response in Gynecologic Malignancies
por: Tse, Ka Yu, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_qgagh84m70otjcqajrv22h6iet